GILEAD SCIENCES INC Insider Trading for April 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GILEAD SCIENCES INC for April 2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 20.74 | 70,000 | 1,451,800 | 20,000 | |
Apr 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 103.97 | 59,761 | 6,213,399 | 165,168 | 224.9 K to 165.2 K (-26.57 %) |
Apr 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 103.06 | 10,239 | 1,055,228 | 224,929 | 235.2 K to 224.9 K (-4.35 %) |
Apr 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 20.74 | 70,000 | 1,451,800 | 235,168 | 165.2 K to 235.2 K (+42.38 %) |
Apr 09 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Option Exercise | M | 19.09 | 5,000 | 95,425 | 34,375 | |
Apr 09 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 100.00 | 5,000 | 500,000 | 145,422 | 150.4 K to 145.4 K (-3.32 %) |
Apr 09 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Buy | M | 19.09 | 5,000 | 95,425 | 150,422 | 145.4 K to 150.4 K (+3.44 %) |
Apr 09 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 80.65 | 205 | 16,533 | 32,640 | |
Apr 09 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 80.65 | 795 | 64,117 | 32,845 | |
Apr 09 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 100.00 | 1,000 | 100,000 | 45,439 | 46.4 K to 45.4 K (-2.15 %) |
Apr 09 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 80.65 | 205 | 16,533 | 46,439 | 46.2 K to 46.4 K (+0.44 %) |
Apr 09 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 80.65 | 795 | 64,117 | 46,234 | 45.4 K to 46.2 K (+1.75 %) |
Apr 03 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 80.65 | 1,000 | 80,650 | 33,640 | |
Apr 03 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 98.04 | 1,000 | 98,044 | 45,439 | 46.4 K to 45.4 K (-2.15 %) |
Apr 03 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 80.65 | 1,000 | 80,650 | 46,439 | 45.4 K to 46.4 K (+2.20 %) |
Apr 03 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Option Exercise | M | 19.09 | 5,000 | 95,425 | 39,375 | |
Apr 03 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 97.13 | 675 | 65,565 | 145,422 | 146.1 K to 145.4 K (-0.46 %) |
Apr 03 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 96.29 | 1,325 | 127,582 | 146,097 | 147.4 K to 146.1 K (-0.90 %) |
Apr 03 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 97.06 | 1,400 | 135,886 | 147,422 | 148.8 K to 147.4 K (-0.94 %) |
Apr 03 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 96.30 | 3,600 | 346,683 | 148,822 | 152.4 K to 148.8 K (-2.36 %) |
Apr 03 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Buy | M | 19.09 | 5,000 | 95,425 | 152,422 | 147.4 K to 152.4 K (+3.39 %) |
Apr 03 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 14.50 | 150,000 | 2,175,375 | 1,200,000 | |
Apr 03 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 97.88 | 4,044 | 395,826 | 4,255,876 | 4.3 M to 4.3 M (-0.09 %) |
Apr 03 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 97.19 | 66,979 | 6,509,970 | 4,259,920 | 4.3 M to 4.3 M (-1.55 %) |
Apr 03 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 96.30 | 78,977 | 7,605,667 | 4,326,899 | 4.4 M to 4.3 M (-1.79 %) |
Apr 03 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 14.50 | 150,000 | 2,175,375 | 4,405,876 | 4.3 M to 4.4 M (+3.52 %) |